vs

Side-by-side financial comparison of Noble Corp plc (NE) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $764.4M, roughly 2.0× Noble Corp plc). Noble Corp plc runs the higher net margin — 11.3% vs 4.4%, a 6.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -17.6%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $35.4M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 9.5%).

Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

NE vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
2.0× larger
ONC
$1.5B
$764.4M
NE
Growing faster (revenue YoY)
ONC
ONC
+50.4% gap
ONC
32.8%
-17.6%
NE
Higher net margin
NE
NE
6.9% more per $
NE
11.3%
4.4%
ONC
More free cash flow
ONC
ONC
$344.4M more FCF
ONC
$379.8M
$35.4M
NE
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
9.5%
NE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NE
NE
ONC
ONC
Revenue
$764.4M
$1.5B
Net Profit
$86.6M
$66.5M
Gross Margin
90.5%
Operating Margin
5.6%
12.4%
Net Margin
11.3%
4.4%
Revenue YoY
-17.6%
32.8%
Net Profit YoY
-10.4%
143.8%
EPS (diluted)
$0.54
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NE
NE
ONC
ONC
Q4 25
$764.4M
$1.5B
Q3 25
$798.0M
$1.4B
Q2 25
$848.7M
$1.3B
Q1 25
$874.5M
$1.1B
Q4 24
$927.3M
$1.1B
Q3 24
$800.5M
$1.0B
Q2 24
$692.8M
$929.2M
Q1 24
$637.1M
$751.7M
Net Profit
NE
NE
ONC
ONC
Q4 25
$86.6M
$66.5M
Q3 25
$-21.1M
$124.8M
Q2 25
$42.9M
$94.3M
Q1 25
$108.3M
$1.3M
Q4 24
$96.6M
$-151.9M
Q3 24
$61.2M
$-121.3M
Q2 24
$195.0M
$-120.4M
Q1 24
$95.5M
$-251.2M
Gross Margin
NE
NE
ONC
ONC
Q4 25
90.5%
Q3 25
86.1%
Q2 25
87.5%
Q1 25
85.2%
Q4 24
85.8%
Q3 24
83.0%
Q2 24
85.1%
Q1 24
83.4%
Operating Margin
NE
NE
ONC
ONC
Q4 25
5.6%
12.4%
Q3 25
6.3%
11.5%
Q2 25
15.9%
6.7%
Q1 25
21.4%
1.0%
Q4 24
18.4%
-7.0%
Q3 24
14.4%
-12.0%
Q2 24
30.3%
-11.5%
Q1 24
16.9%
-34.8%
Net Margin
NE
NE
ONC
ONC
Q4 25
11.3%
4.4%
Q3 25
-2.6%
8.8%
Q2 25
5.1%
7.2%
Q1 25
12.4%
0.1%
Q4 24
10.4%
-13.5%
Q3 24
7.6%
-12.1%
Q2 24
28.1%
-13.0%
Q1 24
15.0%
-33.4%
EPS (diluted)
NE
NE
ONC
ONC
Q4 25
$0.54
$0.05
Q3 25
$-0.13
$0.08
Q2 25
$0.27
$0.06
Q1 25
$0.67
$0.00
Q4 24
$0.56
$-0.10
Q3 24
$0.40
$-0.09
Q2 24
$1.34
$-0.09
Q1 24
$0.66
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NE
NE
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$471.4M
$4.5B
Total DebtLower is stronger
$836.4M
Stockholders' EquityBook value
$4.5B
$4.4B
Total Assets
$7.5B
$8.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NE
NE
ONC
ONC
Q4 25
$471.4M
$4.5B
Q3 25
$477.9M
$4.0B
Q2 25
$338.2M
$2.8B
Q1 25
$303.8M
$2.5B
Q4 24
$247.3M
$2.6B
Q3 24
$391.9M
$2.7B
Q2 24
$162.9M
$2.6B
Q1 24
$212.5M
$2.8B
Total Debt
NE
NE
ONC
ONC
Q4 25
$836.4M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NE
NE
ONC
ONC
Q4 25
$4.5B
$4.4B
Q3 25
$4.5B
$4.1B
Q2 25
$4.6B
$3.8B
Q1 25
$4.7B
$3.5B
Q4 24
$4.7B
$3.3B
Q3 24
$4.7B
$3.4B
Q2 24
$4.0B
$3.4B
Q1 24
$3.9B
$3.4B
Total Assets
NE
NE
ONC
ONC
Q4 25
$7.5B
$8.2B
Q3 25
$7.6B
$7.6B
Q2 25
$7.7B
$6.3B
Q1 25
$7.9B
$5.8B
Q4 24
$8.0B
$5.9B
Q3 24
$8.0B
$5.8B
Q2 24
$5.6B
$5.7B
Q1 24
$5.4B
$5.7B
Debt / Equity
NE
NE
ONC
ONC
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NE
NE
ONC
ONC
Operating Cash FlowLast quarter
$187.1M
$417.3M
Free Cash FlowOCF − Capex
$35.4M
$379.8M
FCF MarginFCF / Revenue
4.6%
25.4%
Capex IntensityCapex / Revenue
19.9%
2.5%
Cash ConversionOCF / Net Profit
2.16×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$432.2M
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NE
NE
ONC
ONC
Q4 25
$187.1M
$417.3M
Q3 25
$277.1M
$402.6M
Q2 25
$216.4M
$263.6M
Q1 25
$271.1M
$44.1M
Q4 24
$136.2M
$75.2M
Q3 24
$283.8M
$188.4M
Q2 24
$106.8M
$-95.6M
Q1 24
$128.7M
$-308.6M
Free Cash Flow
NE
NE
ONC
ONC
Q4 25
$35.4M
$379.8M
Q3 25
$139.5M
$354.5M
Q2 25
$99.8M
$219.8M
Q1 25
$157.5M
$-12.3M
Q4 24
$-4.4M
$-17.3M
Q3 24
$156.8M
$54.7M
Q2 24
$-34.3M
$-205.5M
Q1 24
$-37.9M
$-465.1M
FCF Margin
NE
NE
ONC
ONC
Q4 25
4.6%
25.4%
Q3 25
17.5%
25.1%
Q2 25
11.8%
16.7%
Q1 25
18.0%
-1.1%
Q4 24
-0.5%
-1.5%
Q3 24
19.6%
5.5%
Q2 24
-4.9%
-22.1%
Q1 24
-6.0%
-61.9%
Capex Intensity
NE
NE
ONC
ONC
Q4 25
19.9%
2.5%
Q3 25
17.3%
3.4%
Q2 25
13.7%
3.3%
Q1 25
13.0%
5.0%
Q4 24
15.2%
8.2%
Q3 24
15.9%
13.3%
Q2 24
20.4%
11.8%
Q1 24
26.2%
20.8%
Cash Conversion
NE
NE
ONC
ONC
Q4 25
2.16×
6.28×
Q3 25
3.22×
Q2 25
5.05×
2.79×
Q1 25
2.50×
34.71×
Q4 24
1.41×
Q3 24
4.64×
Q2 24
0.55×
Q1 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NE
NE

Floaters$559.8M73%
Jackups$145.5M19%
Service Other$59.1M8%

ONC
ONC

Segment breakdown not available.

Related Comparisons